3-Chlorobenzyl Cyanide Bulk Price 2026: Market Trends & Sourcing Strategy
- Global bulk prices for industrial-grade 3-Chlorobenzyl cyanide (≥98% purity) are projected to range between $380–$620/kg in 2026 for multi-kilogram orders, driven by raw material volatility and regulatory compliance costs.
- As a key pharmaceutical intermediate, its demand is tightly linked to APIs like lorazepam and novel kinase inhibitors, influencing long-term supply contracts.
- NINGBO INNO PHARMCHEM CO.,LTD. offers scalable production with certified industrial purity, full COA documentation, and competitive bulk pricing aligned with 2026 market forecasts.
As the pharmaceutical and fine chemical sectors prepare for 2026, procurement teams are increasingly focused on securing stable, cost-effective supplies of critical building blocks like 3-Chlorobenzyl cyanide (CAS: 1529-41-5). Also known as (3-Chlorophenyl)acetonitrile or m-Chlorobenzyl cyanide, this compound serves as a pivotal intermediate in the synthesis route for benzodiazepines (e.g., lorazepam), EGFR tyrosine kinase inhibitors, and non-nucleoside reverse transcriptase inhibitors. Understanding current and projected pricing dynamics is essential for strategic sourcing.
2026 Bulk Pricing Landscape for 3-Chlorobenzyl Cyanide
Historical data from global suppliers indicates significant price dispersion based on purity, packaging scale, and regional logistics. While lab-scale quantities (1–100 g) have ranged from $10 to $215, industrial buyers require multi-kilogram or metric-ton volumes where economies of scale apply. Based on aggregated market intelligence and production cost modeling, the anticipated 2026 bulk price for high-purity (≥98%) 3-Chlorophenylacetonitrile is expected to fall within the following brackets:
| Order Volume | Projected 2026 Price Range (USD/kg) | Purity Specification |
|---|---|---|
| 1–5 kg | $520 – $620 | ≥98% (GC), pharma-grade |
| 10–50 kg | $440 – $510 | ≥98% (GC), pharma-grade |
| 100+ kg | $380 – $450 | ≥98% (GC), industrial/pharma dual-use |
These estimates account for rising costs in chlorination reagents, nitrile precursors, and stricter environmental compliance in major manufacturing hubs. Notably, prices for technical-grade material (<95% purity) may dip below $350/kg but are generally unsuitable for regulated pharmaceutical applications due to impurity profiles.
Key Cost Drivers in the Manufacturing Process
The manufacturing process for 3-Chlorobenzyl cyanide typically involves the cyanation of 3-chlorobenzyl chloride using sodium cyanide or alternative cyanide sources under controlled conditions. Yield optimization, waste treatment, and solvent recovery significantly impact final costs. Key variables include:
- Raw Material Sourcing: Fluctuations in benzene derivatives and cyanide salts directly affect input costs.
- Purity Requirements: Pharmaceutical intermediates demand rigorous purification (distillation, crystallization) and analytical validation (GC, HPLC), increasing unit costs versus technical grades.
- Regulatory Compliance: REACH, TSCA, and GHS-aligned safety protocols necessitate investment in closed-system handling and exposure monitoring, especially given its NIOSH IDLH of 25 mg/m³.
- Logistics & Packaging: As a clear liquid (density ~1.283 g/mL) with a flash point >230°F, it requires UN-certified drums with inert headspace for safe transport.
When sourcing high-purity synthesis route materials, buyers should prioritize suppliers offering batch-specific Certificates of Analysis (COA), stability data, and scalable production capacity.
Why Partner with NINGBO INNO PHARMCHEM CO.,LTD.?
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. specializes in the large-scale production of high-value aromatic nitriles, including 3-Chlorobenzyl cyanide. Our integrated facility in China enables end-to-end control over the synthesis route, ensuring consistent industrial purity (≥98.5% by GC), low residual solvents, and full traceability. We support bulk orders from 10 kg to multi-ton campaigns with flexible delivery terms and regulatory documentation (DMF-ready).
Unlike fragmented supply chains that rely on third-party traders, our direct manufacturing model eliminates markups while guaranteeing supply continuity—critical for API developers planning clinical or commercial batches in 2026 and beyond.
Strategic Procurement Recommendations
To mitigate price volatility and ensure quality consistency, B2B buyers should:
- Request samples with full analytical data (GC chromatograms, NMR, water content) before committing to bulk orders.
- Negotiate annual contracts with fixed-price clauses tied to raw material indices.
- Verify supplier capabilities in handling hazardous intermediates and providing GMP-aligned documentation.
With its role as a versatile pharmaceutical intermediate firmly established, 3-Chlorobenzyl cyanide will remain in steady demand through 2026. Partnering with a technically proficient and vertically integrated manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. ensures both cost efficiency and supply chain resilience in an evolving regulatory landscape.